Intravaginal Laser Treatment of Mild and Moderate Stress Incontinence

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03267719

Acronym

laser

Enrollment

Registered

2017-08-30

Start date

2017-08-31

Completion date

2018-09-01

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Incontinence, Female

Brief summary

The aim of the study is to evaluate the effectiveness of laser therapy as a non-surgical treatment option in patients with mild and moderate stress incontinence.

Detailed description

The aim of the study is to evaluate the effectiveness of laser therapy as a non-surgical treatment option in patients with mild and moderate stress incontinence.

Interventions

DEVICElaser therapy

Transvaginal erbium-laser treatment

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Light or moderate stress incontinence * mixed urine incontinence with predominance of the stress component * written informed consent

Exclusion criteria

* Pregnancy * patients treated radiotherapy in the small basin * connective tissue disorders (e.g., Ehlers-Danlos syndrome, Marfan syndrome) * patient with or after malignant disease of the uterus, ovaries, vagina and vulva * former surgery due to stress incontinence (except for the patients who had a TVT insert with removal of the TVT) * Descensus genitalis\> POPQ Stage 1 * former surgery due to a genital lowering with vaginal netting

Design outcomes

Primary

Measure	Time frame	Description
Quality of life	6 month	Quality of life will be access via ICIQ-SF questionaire

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026